aTyr lays off 60% to fund 2nd go at ph. 3 lung disease trial
aTyr lays off 60% to fund 2nd go at ph. 3 lung disease trial
aTyr Pharma
aTyr Pharma is a biopharmaceutical company.
aTyr Pharma is a biopharmaceutical company.
aTyr lays off 60% to fund 2nd go at ph. 3 lung disease trial